Andrew P. Thomas

6.1k total citations · 2 hit papers
82 papers, 5.2k citations indexed

About

Andrew P. Thomas is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Andrew P. Thomas has authored 82 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 15 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Andrew P. Thomas's work include Mitochondrial Function and Pathology (16 papers), Protein Kinase Regulation and GTPase Signaling (14 papers) and Ion channel regulation and function (11 papers). Andrew P. Thomas is often cited by papers focused on Mitochondrial Function and Pathology (16 papers), Protein Kinase Regulation and GTPase Signaling (14 papers) and Ion channel regulation and function (11 papers). Andrew P. Thomas collaborates with scholars based in United Kingdom, United States and Spain. Andrew P. Thomas's co-authors include György Hajnóczky, Jan B. Hoek, Emanuel Rubin, Andrew P. Halestrap, Donald Ogilvie, Elaine S. E. Stokes, Jon Curwen, Laurent Hennequin, Jane Kendrew and Stephen R. Wedge and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Andrew P. Thomas

82 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration.

2002 702 citations Gareth Hughes, Andrew P. Thomas et al. profile →
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family

2012 415 citations Paul R. Gavine, Lorraine Mooney et al. Cancer Research profile →

Peers

Countries citing papers authored by Andrew P. Thomas

Since Specialization

Citations

This map shows the geographic impact of Andrew P. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. Thomas more than expected).

Fields of papers citing papers by Andrew P. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew P. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. Thomas. The network helps show where Andrew P. Thomas may publish in the future.

Co-authorship network of co-authors of Andrew P. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew P. Thomas. A scholar is included among the top collaborators of Andrew P. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew P. Thomas. Andrew P. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High throughput screening of 0.5 million compounds against CRAF using Alpha CETSAⓇ 2023 ·SLAS DISCOVERY ·(unknown), (unknown), (unknown), Delyan P. Ivanov, (unknown), Joseph Shaw, Andrew P. Thomas, Martin J. Packer, (unknown), Geoffrey A. Holdgate	8
2	AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family breakdown → 2012 ·Cancer Research ·Paul R. Gavine, Lorraine Mooney, Elaine Kilgour, Andrew P. Thomas, Katherine Al-Kadhimi, Sarah Beck, Claire Rooney, Tanya Coleman, Dawn Baker, Martine J. Mellor, A. Nigel Brooks, Teresa Klinowska	415
3	AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts 2009 ·Molecular Cancer Therapeutics ·Kate F. Byth, Andrew P. Thomas, Gareth Hughes, (unknown), Alexandra McGregor, Catherine Geh, (unknown), (unknown), Mike Walker, Nicholas J. Newcombe, Stephen Green, Jim Growcott, Andy Barker, Robert W. Wilkinson	104
4	Buffer Optimization of Thermal Melt Assays of Plasmodium Proteins for Detection of Small-Molecule Ligands 2009 ·SLAS DISCOVERY ·Gregory J. Crowther, Alberto J. Napuli, Andrew P. Thomas, (unknown), (unknown), D.J. Leibly, (unknown), Janhavi Bhandari, Christopher J. Damman, Raymond Hui, Wim G. J. Hol, Frederick S. Buckner, Christophe L. M. J. Verlinde, Zhongsheng Zhang, Erkang Fan, Wesley C. Van Voorhis	36
5	Use of thermal melt curves to assess the quality of enzyme preparations 2009 ·Analytical Biochemistry ·Gregory J. Crowther, Panqing He, Philip P. Rodenbough, Andrew P. Thomas, (unknown), D.J. Leibly, Janhavi Bhandari, (unknown), Wim G. J. Hol, Michael H. Gelb, Alberto J. Napuli, Wesley C. Van Voorhis	30
6	Single-Cell and Subcellular Measurement of Intracellular Ca<SUP>2+</SUP> Concentration 2005 ·Humana Press eBooks ·Anthony J. Morgan, Andrew P. Thomas	8
7	Imidazo[1,2- a ]pyridines. Part 2 : SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Kate F. Byth, Janet D. Culshaw, Stephen Green, (unknown), Andrew P. Thomas	95
8	Imidazo[1,2-a]pyridines: A potent and selective class of cyclin-Dependent kinase inhibitors identified through structure-Based hybridisation 2003 ·Bioorganic & Medicinal Chemistry Letters ·Malcolm Anderson, (unknown), Gloria A. Breault, J. Breed, (unknown), Janet D. Culshaw, Rebecca Ellston, Stephen Green, Claire A. Minshull, Richard A. Norman, Richard A. Pauptit, (unknown), Andrew P. Thomas, Philip J. Jewsbury	95
9	Ca ²⁺ marks: Miniature calcium signals in single mitochondria driven by ryanodine receptors 2002 ·Proceedings of the National Academy of Sciences ·Pál Pacher, Andrew P. Thomas, György Hajnóczky	125
10	Calcium Signal Transmission between Ryanodine Receptors and Mitochondria 2000 ·Journal of Biological Chemistry ·Gábor Szalai, György Csordás, Basil M. Hantash, Andrew P. Thomas, György Hajnóczky	194
11	Mitochondria Suppress Local Feedback Activation of Inositol 1,4,5-Trisphosphate Receptors by Ca2+ 1999 ·Journal of Biological Chemistry ·György Hajnóczky, (unknown), Andrew P. Thomas	228
12	Decorin Activates the Epidermal Growth Factor Receptor and Elevates Cytosolic Ca2+ in A431 Carcinoma Cells 1998 ·Journal of Biological Chemistry ·Sandip Patel, Manoranjan Santra, David J. McQuillan, Renato V. Iozzo, Andrew P. Thomas	119
13	Hydroperoxide-induced Increases in Intracellular Calcium Due to Annexin VI Translocation and Inactivation of Plasma Membrane Ca2+-ATPase 1996 ·Journal of Biological Chemistry ·Carolyn R. Hoyal, Andrew P. Thomas, Henry Jay Forman	66
14	Ethanol and Cocaine Cause Additive Inhibitory Effects on the Calcium Transients and Contraction in Single Cardiomyocytes 1996 ·Alcoholism Clinical and Experimental Research ·Josep M. Nicolás, Emanuel Rubin, Andrew P. Thomas	12
15	Heteroligomers of Type-I and Type-III Inositol Trisphosphate Receptors in WB Rat Liver Epithelial Cells 1995 ·Journal of Biological Chemistry ·Suresh K. Joseph, (unknown), (unknown), Andrew P. Thomas, Anthony R. Maranto	120
16	The Effect of Mersalyl on Inositol Trisphosphate Receptor Binding and Ion Channel Function 1995 ·Journal of Biological Chemistry ·Suresh K. Joseph, (unknown), (unknown), (unknown), Andrew P. Thomas	28
17	The inositol trisphosphate calcium channel is inactivated by inositol trisphosphate 1994 ·Nature ·György Hajnóczky, Andrew P. Thomas	147
18	New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties and structure-activity relationships of 2-alkylbenzimidazole derivatives 1992 ·Journal of Medicinal Chemistry ·Andrew P. Thomas, (unknown), Keith H. Gibson, John S. Major, Brian B. Masek, (unknown), Arnold H. Ratcliffe, David A. Roberts, (unknown), (unknown)	81
19	Potentiation by GTP of Ins (1,4,5)P3-Induced Ca2+ Mobilization in Permeabilized Hepatocytes 1988 ·Advances in experimental medicine and biology ·Andrew P. Thomas	1
20	Computer simulation of the effects of α-cyano-4-hydroxycinnamate on gluconeogenesis from l-lactate in rat liver cells 1981 ·Biochemical Journal ·Andrew P. Thomas, Andrew P. Halestrap	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact